Chinese vaccine company Sinovac Biotech Ltd has announced that the age indications for its trivalent and quadrivalent ...

Chinese vaccine company Sinovac Biotech has signed two product development partnership (PDP) agreements with Brazil's health ministry, launching a 10-year collaboration worth more than $700 million.

BEIJING, Sept 24 (Reuters) - China's Sinovac Biotech expects to begin analysing final-stage human trial data on its coronavirus vaccine candidate this year to decide whether it is effective enough to ...

BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading biopharmaceutical company in China, categorically rejects the recent ...

The Board of Directors and Management of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Audit ...

Sinovac Biotech Ltd. (NASDAQ: SVA) shareholder Heng Ren Silk Road Investments LLC today announced that it has heard from more than 100 independent Sinovac shareholders expressing overwhelming support ...

SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is ...

BEIJING, Aug 28 (Reuters) - Sinovac Biotech Ltd's (SVA.O), opens new tab coronavirus vaccine candidate CoronaVac was approved for emergency use as part of a programme in China to vaccinate high-risk ...

SAIF Partners Urges Shareholders to Vote the GOLD Proxy Card “FOR” its Director Candidates to End Years of Chaos, Restore Credibility and Unlock Long-Term Value for All Sinovac Shareholders SAIF ...

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the Company has obtained approval to begin human clinical trials on its Sabin ...